Savvy Psychopharmacology

Impact of the MTHFR C677T genetic variant on depression

Author and Disclosure Information

 

References

Related Resources

  • Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 2007;165(1):1-13.
  • Trimmer E. Methylenetetrahydrofolate reductase: biochemical characterization and medical significance. Current Pharmaceutical Design. 2013;19(4):2574-3595.

Drug Brand Names

Citalopram • Celexa
Duloxetine • Cymbalta
Escitalopram • Lexapro
Fluoxetine • Prozac
L-methylfolate • Deplin
Mirtazapine • Remeron
Paroxetine • Paxil
Sertraline • Zoloft

Pages

Recommended Reading

Evaluate, manage the stress response in susceptible individuals affected by COVID-19
MDedge Psychiatry
Counterintuitive findings for domestic violence during COVID-19
MDedge Psychiatry
The gut a new therapeutic target for major depression?
MDedge Psychiatry
Reassuring findings on SSRIs and diabetes risk in children
MDedge Psychiatry
ECG promising for predicting major depression, treatment response
MDedge Psychiatry
Breathing enriched oxygen improves major depression
MDedge Psychiatry
Suicide rates up significantly among adolescents, young adults
MDedge Psychiatry
Suicidality jumped in Israel during spring COVID-19 lockdown
MDedge Psychiatry
Listening to Tim Ferriss
MDedge Psychiatry
Cognitive impairments in major depression cluster in three patterns
MDedge Psychiatry